OraSure Technologies, Inc. (OSUR)

Market Cap	233.00M
Revenue (ttm)	161.63M
Net Income (ttm)	-31.96M
Shares Out	74.80M
EPS (ttm)	-0.43
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,084,892
Open	3.130
Previous Close	3.070
Day's Range	3.050 - 3.150
52-Week Range	2.360 - 4.920
Beta	0.45
Analysts	Hold
Price Target	3.00 (-3.69%)
Earnings Date	Aug 5, 2025

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company’s products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid te...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 12, 1986
• Employees: 501
• Stock Exchange: NASDAQ
• Ticker Symbol: OSUR
• Website: https://www.orasure.com

Analyst Summary

According to one analyst, the rating for OSUR stock is "Hold" and the 12-month stock price target is $3.0.

Price Target

$3.0

(-3.69% downside)

Analyst Consensus: Hold